naloxone + lofexidine

Naloxone + lofexidine is a combination of two drugs, naloxone and lofexidine, each with distinct mechanisms of action. Naloxone is an opioid receptor antagonist that rapidly reverses the effects of opioids by competitively inhibiting μ-opioid receptors, making it essential in the management of opioid overdose[4]. Lofexidine is a centrally acting alpha-2A-adrenergic receptor agonist used to mitigate symptoms associated with acute opioid withdrawal; it reduces autonomic symptoms such as chills, sweating, stomach cramps, and muscle pain without being an opioid itself[2][3][5]. While both drugs are individually approved for specific indications related to opioid use and withdrawal management, there is no evidence or approval for a fixed-dose combination product containing both naloxone and lofexidine. Each drug may be used separately or as part of broader protocols in managing different aspects of opioid dependence or withdrawal.